share_log

Parexel, Parexel Announce Multi-year Strategic Partnership To Leverage AI To Help Enhance And Accelerate Delivery Of Safe And Effective Clinical Trials

Benzinga ·  Apr 25 07:23

Under the collaboration, Parexel will leverage Palantir's Foundry and Artificial Intelligence Platform (AIP) to further power its clinical data platform, focused on driving clinical trial efficiency while maintaining the highest level of safety and regulatory rigor. Parexel is the first CRO working with Palantir in this capacity, building on the companies' existing collaboration over the past year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment